Pfizer Inc. is taken as case study for an innovative company in the pharmaceutical sector. Firstly, the author will look at its mission statement in relation to its key stakeholders. Secondly, the company’s overall strategy will be outlined regarding its positioning on the market as well the linkage to key theories which will be discussed and applied. The third part focuses on Pfizer’s operational issues. Finally a comparison of the strategic performance and application of theories between Microsoft and Pfizer, both, two highly innovative companies, will be made.
Pfizer, as the main case study, was chosen, because it can be defined as a highly innovative company, ranking globally the second by R&D expenditure on the DTI R&D scoreboard (see Appendix 1). However, according to the ‘Business Week’ the company ranks only on place 55 in the world’s most innovative companies, with a margin growth of 1.8% and stock returns of 9.9% between 1995 till 2005. (Business Week, 2006) This provides the evidence that Pfizer is an innovative company.
Table of Contents
1. Introduction
2. Pfizer Inc.
2.1 Mission Statement - Pfizer
2.2 Strategic Statements & Layers of Pfizer
2.3 Operational Dimension of Pfizer
3. Executive Summary
4. Comparison: Microsoft & Pfizer
Objectives and Key Themes
This assignment serves as a comprehensive case study on Pfizer Inc., exploring its positioning as an innovative firm. The work examines the company's mission statement, corporate strategy, operational management, and stakeholder relations within the pharmaceutical industry. A critical component involves comparing Pfizer’s strategic performance and innovation approach with those of Microsoft, highlighting differences in industry dynamics and organizational management.
- Analysis of Pfizer’s mission statement and alignment with key stakeholder expectations.
- Evaluation of Pfizer’s strategic statements, core competencies, and competitive positioning.
- Examination of operational challenges, including R&D intensity and organizational restructuring.
- Comparative assessment of innovation models between Pfizer and Microsoft.
Excerpt from the Book
2.2 Strategic Statements & Layers of Pfizer
Among others, five strategic statements can be outlined according to the Annual Report 2006;
1) Maximising revenues in the short and in the long term through
2) Establish a lower and more flexible cost base through
3) Create smaller, more accountable operating units that will enhance innovation and draw on the advantages of our scale and resources.
4) Actively and more meaningfully engage with customers, patients, physicians and other collaborators to provide them with greater value
5) Make Pfizer a great place to work
Porter (1985, cited by De Witt and Meyer, 2004) states that “competition is the core of success or failure of firms”. Porter assumes that the factors determining industry competitiveness and attractiveness are driven by rather external than internal factors. Thus, distinctive firm characteristics on the company’s competitive position are not highly stressed out as Porter (1980, cited by Barney, 1991) emphasises the obtaining of sustained competitive advantages through reacting to the external opportunities by the given internal strengths. Porter (1980) conducted a theory of five competitive forces (see Appendix 3) which emphasises all elements that may drive competition in an industry. This model would suit Pfizer’s first strategic statement as well as his generic strategies, which can be applied, because the company has a strong current product portfolio, including the world’s best selling medicine, Liptor and future product pipelines which are in R&D terms the largest of Pfizer’s history and “include promising new therapies for Alzheimer’s disease, cancer, diabetes, HIV, obesity and other unmet medical needs.” (Pfizer, Annual Report, 2006) Therefore, strategic strength is the focus on its core competencies while achieving product differentiation, by offering many different product lines (including innovative products such as Viagra) as well as cost efficiency due to its economies of scale in global terms in order sustain competitive
Summary of Chapters
1. Introduction: Outlines the scope of the case study, focusing on Pfizer as an innovative company, its mission, strategy, and operational performance in comparison to Microsoft.
2. Pfizer Inc.: Provides a company overview, discussing its founding, global reach, and the importance of R&D in the pharmaceutical sector.
2.1 Mission Statement - Pfizer: Analyzes the company’s mission in the context of stakeholder theory, emphasizing the priority placed on investors and other key groups.
2.2 Strategic Statements & Layers of Pfizer: Details the five key strategic objectives of the firm and relates them to Porter’s competitive force model and core competencies.
2.3 Operational Dimension of Pfizer: Examines how the company manages R&D, cross-functional teamwork, and restructuring to maintain a competitive advantage.
3. Executive Summary: Summarizes the challenges of the innovation gap in the pharmaceutical industry and how Pfizer addresses this through R&D and strategic adaptation.
4. Comparison: Microsoft & Pfizer: Contrasts the two industry leaders regarding their innovation strategies, stakeholder focus, and organizational management structures.
Keywords
Pfizer, Innovation, Research and Development, R&D, Pharmaceutical Industry, Strategic Management, Stakeholder Theory, Competitive Advantage, Value Innovation, Corporate Strategy, Market Positioning, Business Restructuring, Microsoft, Core Competencies, Operational Excellence
Frequently Asked Questions
What is the primary focus of this assignment?
The assignment serves as a case study for Pfizer Inc., investigating its innovative capacity, corporate strategy, and operational effectiveness within the global pharmaceutical market.
What are the central themes discussed in the paper?
The core themes include R&D expenditure, stakeholder management, the impact of patent expirations, organizational restructuring, and the application of strategic management theories.
What is the main objective of the study?
The objective is to outline Pfizer’s positioning on the market, analyze its mission and strategic objectives, and compare its innovation performance with that of Microsoft.
Which scientific methodology is applied?
The study utilizes a qualitative case study approach, applying management theories such as Porter’s Five Forces, stakeholder theory, and concepts of core competency to analyze Pfizer’s business model.
What topics are covered in the main body of the work?
The main body covers the company's mission statement, specific strategic layers, operational activities like R&D management and cross-functional teams, and a comparative analysis with Microsoft.
Which keywords best describe this research?
Key terms include Innovation, R&D, Stakeholder Theory, Pharmaceutical Industry, Competitive Advantage, and Strategic Management.
How does Pfizer address the "innovation gap"?
Pfizer addresses the innovation gap primarily by prioritizing R&D investments, forming strategic alliances, acquiring external know-how, and restructuring operations to improve efficiency.
What is the primary difference between Pfizer's and Microsoft's innovation approaches?
Pfizer relies heavily on incremental innovation driven by massive R&D expenditure and shareholder focus, whereas Microsoft emphasizes "value innovation" centered on customer satisfaction and marketing.
- Quote paper
- Miriam Mennen (Author), 2007, Innovation & Growth - A case study of Pfizer, Munich, GRIN Verlag, https://www.grin.com/document/145364
